In healthy subjects and patients with cardiovascular disease, aspirin was found to be less potent than P2Y12 inhibition, or possibly without effect, in reducing platelet-leukocyte aggregate formation16,17. This evidence concerns the gene P2RY12 and cardiovascular disorder.